Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners

Bassel Tarakji, Giath Gazal, Sadeq Ali Al-Maweri, Saleh Nasser Azzeghaiby, Nader Alaizari, Bassel Tarakji, Giath Gazal, Sadeq Ali Al-Maweri, Saleh Nasser Azzeghaiby, Nader Alaizari

Abstract

Recurrent aphthous stomatitis (RAS) is a well-known oral disease with unclear etiopathogenesis for which symptomatic therapy is only available. This kind of study aimed to highlight the main points that the general practitioners should be taken in their consideration. We have collected our data from PubMed line from 1972 to 2011. Our criteria included the papers that refer to the general predisposing factors, and the general treatment of RAS. Some papers which indicated to the specific details related to RAS that needed a consultant or specialist in Oral Medicine have not included. There is no clear guideline of the etiology, diagnosis, and management of RAS; therefore, the majority of the general practitioners refer most of the cases to appropriate specialist.

Keywords: Aphthous stomatitis; etiological factors; major aphthous stomatitis.

Conflict of interest statement

Conflicts of Interest: None

Figures

Figure 1
Figure 1
Minor aphthous ulceration.
Figure 2
Figure 2
Major aphthous ulceration.
Figure 3
Figure 3
Herpetiform ulceration.

References

    1. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm. 2001;58(1):41–50.
    1. Stanley HR. Aphthous lesions. Oral Surg Oral Med Oral Pathol. 1972;33(3):40716.
    1. Rogers RS., 3rd Recurrent aphthous stomatitis: Clinical characteristics and associated systemic disorders. Semin Cutan Med Surg. 1997;16(4):278–83.
    1. Scully C, Porter S. Recurrent aphthous stomatitis: Current concepts of etiology, pathogenesis and management. J Oral Pathol Med. 1989;18(1):21–7.
    1. Sircus W, Church R, Kelleher J. Recurrent aphthous ulceration of the mouth;a study of the natural history, aetiology, and treatment. Q J Med. 1957;26(102):235–49.
    1. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2005;49(1):31–47. vii.
    1. Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R. Recurrent aphthous ulcers today: A review of the growing knowledge. Int J Oral Maxillofac Surg. 2004;33(3):221–34.
    1. Boldo A. Major recurrent aphthous ulceration: Case report and review of the literature. Conn Med. 2008;72(5):271–3.
    1. Shashy RG, Ridley MB. Aphthous ulcers: A difficult clinical entity. Am J Otolaryngol. 2000;21(6):389–93.
    1. McCullough MJ, Abdel-Hafeth S, Scully C. Recurrent aphthous stomatitis revisited;clinical features, associations, and new association with infant feeding practices? J Oral Pathol Med. 2007;36(10):615–20.
    1. Dolby AE. Recurrent Mikulicz’s oral apthae. Their relationship to the menstrual cycle. Br Dent J. 1968;124(8):359–60.
    1. Bishop PM, Harris PW, Trafford JA. Oestrogen treatment of recurrent aphthous mouth ulcers. Lancet. 1967;1(7504):1345–7.
    1. Kvam E, Gjerdet NR, Bondevik O. Traumatic ulcers and pain during orthodontic treatment. Community Dent Oral Epidemiol. 1987;15(2):104–7.
    1. Wray D, Graykowski EA, Notkins AL. Role of mucosal injury in initiating recurrent aphthous stomatitis. Br Med J (Clin Res Ed) 1981;283(6306):1569–70.
    1. Boulinguez S, Cornée-Leplat I, Bouyssou-Gauthier ML, Bedane C, Bonnetblanc JM. Analysis of the literature about drug-induced aphthous ulcers. Ann Dermatol Venereol. 2000;127(2):155–8.
    1. Healy CM, Thornhill MH. An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs. J Oral Pathol Med. 1995;24(1):46–8.
    1. Hay KD, Reade PC. The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity. Oral Surg Oral Med Oral Pathol. 1984;57(5):504–7.
    1. Eversole LR, Shopper TP, Chambers DW. Effects of suspected foodstuff challenging agents in the etiology of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol. 1982;54(1):33–8.
    1. Besu I, Jankovic L, Magdu IU, Konic-Ristic A, Raskovic S, Juranic Z. Humoral immunity to cow’s milk proteins and gliadin within the etiology of recurrent aphthous ulcers? Oral Dis. 2009;15(8):560–4.
    1. Porter SR, Scully C, Flint S. Hematologic status in recurrent aphthous stomatitis compared with other oral disease. Oral Surg Oral Med Oral Pathol. 1988;66(1):41–4.
    1. Nolan A, McIntosh WB, Allam BF, Lamey PJ. Recurrent aphthous ulceration: Vitamin B1, B2 and B6 status and response to replacement therapy. J Oral Pathol Med. 1991;20(8):389–91.
    1. Gallo Cde B, Mimura MA, Sugaya NN. Psychological stress and recurrent aphthous stomatitis. Clinics (Sao Paulo) 2009;64(7):645–8.
    1. Mirbod SM, Ahing SI. Tobacco-associated lesions of the oral cavity: Part I. Nonmalignant lesions. J Can Dent Assoc. 2000;66(5):252–6.
    1. McRobbie H, Hajek P, Gillison F. The relationship between smoking cessation and mouth ulcers. Nicotine Tob Res. 2004;6(4):655–9.
    1. Hill SC, Stavrakoglou A, Coutts IR. Nicotine replacement therapy as a treatment for complex aphthosis. J Dermatolog Treat. 2010;21(5):317–8.
    1. Mattingly G, Rodu B. Differential diagnosis of oral mucosal ulcerations. Compendium. 1993;14(2):136.
    1. Rodu B, Mattingly G. Oral mucosal ulcers: Diagnosis and management. J Am Dent Assoc. 1992;123(10):83–6.
    1. Fenton SJ, Unkel JH. Viral infections of the oral mucosa in children: A clinical review. Pract Periodontics Aesthet Dent. 1997;9(6):683–90.
    1. Lozada F, Silverman S., Jr Erythema multiforme. Clinical characteristics and natural history in fifty patients. Oral Surg Oral Med Oral Pathol. 1978;46(5):628–36.
    1. Brown RS, Bottomley WK, Puente E, Lavigne GJ. A retrospective evaluation of 193 patients with oral lichen planus. J Oral Pathol Med. 1993;22(2):69–72.
    1. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(5):517–34.
    1. Terezhalmy GT, Bergfeld WF. Cicatricial pemphigoid (benign mucous membrane pemphigoid) Quintessence Int. 1998;29(7):429–37.
    1. Kozlak ST, Walsh SJ, Lalla RV. Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis. J Oral Pathol Med. 2010;39(5):420–3.
    1. Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M. Recurrent aphthous stomatitis. Quintessence Int. 2000;31(2):95–112.
    1. Casiglia JM. Recurrent aphthous stomatitis: Etiology, diagnosis, and treatment. Gen Dent. 2002;50(2):157–66.
    1. Al-Na’mah ZM, Carson R, Thanoon IA. Dexamucobase: A novel treatment for oral aphthous ulceration. Quintessence Int. 2009;40(5):399–404.
    1. Meng W, Dong Y, Liu J, Wang Z, Zhong X, Chen R, et al. A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: A randomized, placebo controlled, blinded, multicenter clinical trial. Trials. 2009;10:30.
    1. Pakfetrat A, Mansourian A, Momen-Heravi F, Delavarian Z, Momen-Beitollahi J, Khalilzadeh O, et al. Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial. Clin Invest Med. 2010;33(3):E189–95.
    1. de Abreu MA, Hirata CH, Pimentel DR, Weckx LL. Treatment of recurrent aphthous stomatitis with clofazimine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):714–21.
    1. Weckx LL, Hirata CH, Abreu MA, Fillizolla VC, Silva OM. Levamisole does not prevent lesions of recurrent aphthous stomatitis: A double-blind placebo-controlled clinical trial. Rev Assoc Med Bras. 2009;55(2):132–8.
    1. Kaya EG, Ozbilge H, Ustundag MB, Torun YA. The effects on immune response of levamisole treatment following infection of U-937 macrophages with Candida albicans. Acta Microbiol Immunol Hung. 2011;58(4):279–88.
    1. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol. 1994;30(4):603–21.
    1. Schwarz A, Krone C, Trautinger F, Aragane Y, Neuner P, Luger TA, et al. Pentoxifylline suppresses irritant and contact hypersensitivity reactions. J Invest Dermatol. 1993;101(4):549–52.
    1. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med. 1999;159(2):508–11.
    1. D’Hellencourt CL, Diaw L, Cornillet P, Guenounou M. Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol. 1996;18(12):739–48.
    1. Tilg H, Eibl B, Pichl M, Gächter A, Herold M, Brankova J, et al. Immune response modulation by pentoxifylline in vitro. Transplantation. 1993;56(1):196–201.
    1. Ship JA. Recurrent aphthous stomatitis: An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(2):141–7.
    1. Modschiedler K, Weller M, Wörl P, von den Driesch P. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. Arch Dermatol Res. 2000;292(1):32–6.
    1. Tezel A, Kara C, Balkaya V, Orbak R. An evaluation of different treatments for recurrent aphthous stomatitis and patient perceptions: Nd: YAG laser versus medication. Photomed Laser Surg. 2009;27(1):101–6.
    1. Chavan M, Jain H, Diwan N, Khedkar S, Shete A, Durkar S. Recurrent aphthous stomatitis: A review. J Oral Pathol Med. 2012;41(8):577–83.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren